Concepedia

James R. Lambert

JR

Statistics

Publications

28

Citations

1.2K

H-Index

21

Active since

1993

Affiliations

University of Colorado Denver(Current)

University of Colorado Anschutz Medical Campus

Boston University

University of Colorado Health

University of Colorado Hospital

James R. Lambert is an author at University of Colorado Denver specializing in oncology, life sciences, and molecular oncology.

ORCID

Publications per year

1993–2024

28

Publications

28

Aberrant HOXC expression accompanies the malignant phenotype in human prostate.

Gary J. Miller, Heidi L. Miller, Adrie van Bokhoven et al. · PubMed · 2003 · 171 citations

, , +16

Prostate derived factor in human prostate cancer cells: Gene induction by vitamin D via a p53‐dependent mechanism and inhibition of prostate cancer cell growth

James R. Lambert, Julie Kelly, Minsub Shim et al. · Journal of Cellular Physiology · 2006 · 83 citations

, , +16

MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells

Nabanita Mukherjee, Jenette Skees, Kaleb J. Todd et al. · Cell Death and Disease · 2020 · 72 citations · Full text

, , +17

Endocrine Disrupting Activities of the Flavonoid Nutraceuticals Luteolin and Quercetin

Steven K. Nordeen, B J Bona, David N. M. Jones et al. · Hormones and Cancer · 2013 · 66 citations · Full text

, , +10

Reversal of Triple-Negative Breast Cancer EMT by miR-200c Decreases Tryptophan Catabolism and a Program of Immunosuppression

Thomas J. Rogers, Jessica L. Christenson, Lisa I. Greene et al. · Molecular Cancer Research · 2018 · 65 citations · Full text

, , +14

1–5 of 28